Froimson Mark

Director at PCRX

Sold, on record
$123k
Dollars the filings state
Form 4 sales
3
Latest Mar 17, 2026
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • PCRXPacira BioSciences, Inc.Director

Sales by reason

0
Routine
0
Plan not stated
1
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale PCRXPlan not stated
    Mar 15 2021

    Sold 734 shares at $72.26 ($53k)

    Froimson Mark, Director

    Sold 12.3% of holdings ($432k position)5,242 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale PCRXPlan not stated
    May 9 +420 days

    Sold 1,000 shares at $59.37 ($59k)

    Froimson Mark, Director

    Sold 16.9% of holdings ($351k position)4,908 shares leftFiling

  3. 3 Form 4 sale PCRXNo plan
    Mar 17 +1408 days

    Sold 500 shares at $21.81 ($11k)

    Froimson Mark, Director

    No 10b5-1 planSold 2.4% of holdings ($450k position)20,136 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Froimson Mark
Source
Mar 17, 2026PCRXDirectorForm 4 sale500$11k2.4%No planSEC
May 9, 2022PCRXDirectorForm 4 sale1,000$59k16.9%Plan not statedSEC
Mar 15, 2021PCRXDirectorForm 4 sale734$53k12.3%Plan not statedSEC